Skip to main content

Table 1 Demographics and clinical characteristics of patients

From: Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection

Age (years)

 Mean ± SD

51.36 ± 6.98

Sex

 Female (n, % of total)

22 (55%)

 Male (n,% of total)

18 (45%)

Type of ttt

 Insulin (n, % of total)

16 (40%)

 Oral(n,% of total)

24 (60%)

No of injections (mean ± SD)

3.52 ± 1.4

BCVA before injection (mean ± D)

0.95 ± 0.21

BCVA after 6 months

 mean ± SD

0.51 ± 0.23

 Median (IQR)

0.4 (0.3–0.7)

Duration of DM Median (IQR)

10 (7–15)

HbA1c

8.76 ± 0.99

  1. n Number, BCVA Best corrected visual acuity, SD Standard deviation, DM Diabetes mellitus, IQR Interquartile range, HbA1c Hemoglobin A1c